VRTX Related Options
-
Stocks with implied volatility below IV index mean; VRTX GMCR
-
Stocks with implied volatility below IV index mean; VRTX FOSL
-
Stocks with implied volatility below IV index mean; VRTX GMCR
-
Vertex (VRTX) volatility flat as shares rally 54% on improved lung function treatement
-
Stocks with call strike movement; VRTX SWN
-
Vertex Pharma (VRTX) volatility elevated at 58
-
Stocks with call strike movement; VRTX BAC
-
Vertex Pharma (VRTX) volatility elevated as shares sell off on AASLD meeting update.
-
Call option volume increases: AMGN VRTX MBI GFI
-
Vertex Pharma (VRTX) June volatility elevated into data
-
Goldman Sachs Recommends Vertex Pharmaceuticals (VRTX) Call Options
-
Vertex Pharma (VRTX) volatility elevated at 58 into PDUFA
-
Vertex Pharma (VRTX) July volatility elevated into PDUFA
-
Vertex Pharma (VRTX) volatility elevated into trials
-
Vertex Pharma (VRTX) May put volatility at 83, July at 67 into trials
-
Vertex Pharma (VRTX) April volatility at 33, July at 47 into ADVANCE trial
-
Vertex Pharma (VRTX) April volatility at 42, July at 53 into events
-
Vertex Pharma (VRTX) January puts spreaders active on low volatility
-
Vertex Pharma (VRTX) volatility at low end of range
-
Vertex Pharma (VRTX) volatility at low end of range
-
Vertex Pharma (VRTX) April option prices Elevated into Telaprevir Update
-
Vertex Pharma (VRTX) option implied volatility increases into Telaprevir presentation
-
Vertex Pharma (VRTX) April option implied volatility Elevated at 94 into Telaprevir Data
-
Vertex Pharma (VRTX) April implied volatility Elevated at 90 into Telaprevir presentation
-
Vertex Pharmaceuticals (VRTX) option implied volatility Elevated into data release
-
Vertex Pharmaceuticals (VRTX) near term option prices Elevated into Data
-
American Society of Clinical Oncology (ASCO) participants June stock option implied Volatility - Part 3
Back to VRTX Stock Lookup
